Lexaria Bioscience (LEXX) Stock: Buy, Sell, or Hold?
LEXX - Lexaria Bioscience Corp. Common Stock
$2.94
0.06 (1.91%)
▲
5d:
-8.99%
30d:
-76.18%
90d:
+453.46%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 25, 2026
Get Alerted When LEXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LEXX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LEXX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LEXX is currently trading at $2.94, which is considered slightly low relative to its 30-day fair value range of $1.99 to $9.92.
Technical Outlook: Technically, LEXX is in a strong uptrend. Immediate support is located at $2.80, while resistance sits at $3.84.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $82.50 (+2764.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEXX is in a strong uptrend. Immediate support is located at $2.80, while resistance sits at $3.84.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $82.50 (+2764.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.99 -
$9.92
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2764.6% below Wall St target ($82.50)
- NEUTRAL: Bottoming setup forming (53/100) — watch for confirmation
- CAUTION: 5-day price weakness (-9.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.99 -
$9.92
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.80
Resistance Level
$3.84
Current Trend
Strong Uptrend
Technical data as of
Oct 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.62
Wall Street Target
$82.50
(+2764.6%)
Revenue Growth (YoY)
-88.5%
Share & Embed Analysis
Last updated: October 05, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEXX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$853 | 53 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
19 analysts |
$644 | 59 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 57 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
13 analysts |
$74 | 66 BUY |
